Skip to content

Selective Laser Trabeculoplasty for Primary Angle-Closure Glaucoma: a pilot case study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN42557387
Enrollment
150
Registered
2006-07-03
Start date
2005-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary angle-closure glaucoma Eye Diseases Glaucoma

Interventions

Sponsors

Ellex Medical Pty. Ltd. (Australia)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. PACG 2. Intraocular pressure 21 - 28 mmHg on one or more topical medicine in presence of patent iridotomy 3. At least two months since last iridotomy 4. Aged over 21 years old

Exclusion criteria

Exclusion criteria: 1. Secondary causes of angle-closure 2. Corneal abnormalities 3. Advanced glaucomatous optic neuropathy 4. Patient blind in one eye

Design outcomes

Primary

MeasureTime frame
Intraocular pressure (IOP) at regular intervals of follow-up with the final IOP being measured at six months after the last treatment. Successful outcome defined as greater or equal to 20% reduction in IOP from pre-laser levels.

Secondary

MeasureTime frame
IOP measured on other eye if both eyes are eligible for the study.

Countries

Hong Kong, Philippines, Singapore, Thailand

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026